Adenoviral-mediated overexpression of platelet-derived growth factor-b corrects ischemic impaired wound healing

Journal of Investigative Dermatology

Volumn 113, Issue 3, 1999, Pages 375-383

  Liechty, Kenneth W ^a   Nesbit, Mark ^b   Herlyn, Meenhard ^b   Radu, Antoneta ^a   Scott Adzick, N ^a   Crombleholme, Timothy M ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Adenovirus; Gene therapy; Skin

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIZATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; TRANSGENE; VIRUS PLAQUE; WOUND HEALING;

EID: 0032836753     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00705.x     Document Type: Article

References (46)

1. Ahn ST, Mustoe TA: Effects of ischemia on ulcer wound healing: a new model in the rabbit cat. Ann Plast Surg 24:17-23, 1990
2. Andree C, Swain WF, Page CP, Macklin MD, Slama J, Hatzis D, Eriksson E: In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci USA 91:12188-12192, 1994
3. Benn SI, Whitsitt JS, Broadley KN, et al: Particle-mediated gene transfer with transforming growth factor-β1 cDNAs enhance wound repair in rat skin. J Clin Invest 98:2894-2902, 1996
4. Bett AJ, Prevec L, Graham FL: Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 67:5911-5921, 1993
5. Chen CA, Okayama H: Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6:632-638, 1988
6. Chen TL, Bates RL, Xu Y, Ammann AJ, Beck LS: Human recombinant transforming growth factor-beta 1 modulation of biochemical and cellular events in healing of ulcer wounds. J Invest Dermatol 98:428-435, 1992
7. Chleboun JO, Martins R, Rao S: Laser Doppler velocimetry and platelet derived growth factor as prognostic indicators for the healing of ulcers and ischaemic lesions of the lower limb, Cardiovascular Surg 3:285-290, 1995
8. Chornczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156 159, 1987
9. Collins T, Ginsburg D, Boss JM, Orkin SH, Poher JS: Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 316:748-750, 1985
10. Culling CFA (ed.): Handbook of histopathological and histochemical techniques. London: Butterworth and Co., 1974
11. Davis AR, Wilson JM. Adenoviral vectors, In: Dracopoli NC, Haines JL, Korf BR, et al (eds). Current Protocols in Human Genetics. New York: John Wiley & Sons, Inc., 1994, pp 12.4.1
12. Eming SA, Lee J, Snow RG, Tompkins RG, Yarmush ML, Morgan JR: Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice-Implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J Invest Dennatol 6:756-763, 1995
13. Eming SA, Medalie DA, Tompkins RG, Yarmush MT, Morgan JR: Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum Gene Ther 9:529-539, 1998
14. Folanga V, Eaglstein WH: The trap hypothesis of venous ulceration, Lancet 341:1006-1008, 1993
15. Gilliland G, Perrin S, Blanchard K, Bunn F: Analysis of cytokine mRNA and DNA, detection and quantification by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87:2725-2729, 1990
16. Graham FL, Eb AJ, v.d. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467, 1973
17. Grinnell F, Ho C-H, Wysocki A: Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting and immunoblotting and cell adhesion Assays J Invest Dermatol 98:410-416, 1992
18. Grubb BR, Pickles RJ, Ye H, et al: Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371:802-806, 1994
19. Harlan JM, Thompson PJ. Ross R, Bowen-Pope DF: α-Thrombin induces, release of PDGF-like molecule(s) by cultured human endothelial cells. J Cell Biol 103:1129-1133, 1986
20. Heldin P, Laurent TC, Heldin C-H: Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 258:919-922, 1989
21. Hirt B: Selective extraction of polyoma DNA from infected mouse cell cultures, J Mol Biol 26:365-369, 1967
22. Johnsson A, Betsholtz C. Heldin CH, Westermark B: The phenotypic characteristics of simian sarcoma virus, transformed human fibroblasts suggest that the v-sis gene product acts solely as a PDGF receptor agonist in cell transformation. EMBO J 5:1535-1541, 1986
23. Kaplan DR, Chao FC, Stiles CD, Antomades HN, Seher CD: Platelet alpha granules contain a growth factor for fibroblasts. Blood 53:1043-1052, 1979
24. Kozarsky KF, Wilson JM: Gene therapy: adenovirus vectors. Curr Opin Genet Dev 3:499-503, 1993
25. Kozarsky K, Grossman M, Wilson JM: Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Somat Cell Mol Genet 19:449-458. 1993
26. Krueger GG, Morgan JR, Jorgensen CM, et al: Genetically modified skin to treat disease: potential and limitations. J Invest Dermatol 103:76s-84s, 1994
27. Li DQ, Tseng SC: Differential regulation of keratinocyte growth factor and hepatocyte growth factor/scatter factor by different cytokines in human corneal and limbal fibroblasts. J Cell Physiol 172:361-372, 1997
28. Lu B, Federoff HF, Wang Y, Goldsmith LA. Scott G: Topical application of vital vectors for epidermal gene transfer. J Invest Dermatol 108:803-808, 1997
29. Mastov EN: Diagnosis and classification of chronic wounds, Clin Dermatol 12:3-9, 1994
30. Mustoc TA, Pierce GF, Morishima C, Deuel TF: Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest 87:694-703, 1991
31. Mustoe TA, Cutler NR, Allman RM, et al: A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and stage 4 pressure ulcers. Arch Surg 129:213-219, 1994
32. Paulsson Y, Hammacher A, Heldin C-H, Westermark B: Possible positive autocrine feedback in the prerephcative phase of human fibroblasts. Nature 328:715-717, 1987
33. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Gramates P, Deuel TF: Transforming growth factor-B revises the glucocorticoid-induced wound healing deficit in rats and is regulated by platelet-derived growth factor in macrophages. Proc Natl Acad Sci USA 86:2229-2233, 1989
34. Pierce GF, Vande Berg J, Rudolph R, Tarpley J, Mustoe TA: Platelet-derived growth factor-BB and transforming growth factor beta I selectivety modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds, Am J Pathol 138:629-646, 1991
35. Pierce GF, Tarpley JE, Tseng J, et al: Detection of platelet-derived growth factor (PDGF) -AA in actively healing wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nohealing wounds. J Clin Invest 96:1336-1350, 1995
36. Poon M, Hsu WC, Bogadanov VY, Taubman MB: Secretion of monocyte chemotactic activity by cultured rat aortic smooth muscle cells in response to PDGF is due predominantly to the induction of JE/MCP-1. Am J Pathol 149:303-317, 1996
37. Ranheim TS, Shisler J, Horton TM, Wold LJ, Gooding LR, Wold WS: Characterization of mutants with the gene for the adenovirus E3, 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. J Virol 67:2159-2167, 1993
38. Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF: Platelet-derived growth factor BB for the treatment of chronic pressure ulcers, Lancet 339:23-25, 1992
39. Sakai D. Tong HS, Minkin C: Osteoclast molecular phenotyping by random cDNA sequencing. Bone 17:111-119, 1995
40. Sambrook J. Fritsch EF, Maniatis T: Molecular Cloning: a laboratory Manual Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989
41. Sato N, Beitz JG, Kato J, Yamamoto M, Clark JW, Calabresi P, Raymond A, Frackelton AR Jr: Platelet derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 142:1119-1130, 1993
42. Seppa HEJ, Grotendorst GR, Seppa SI, Schiffman E, Martin GR: Platelet-derived growth factor is chemotactic for fibroblasts. J Cell Biol 92:584-588, 1982
43. Shimokado K, Raines EW, Madtes DK, Barrett TB, Benditt EP, Ross R: A significant part off macrophage-derived growth factor consists of at least two forms of PDGF. Cell 43:277-286, 1985
44. Steed DL: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group J Vasc Surg 21:79-81, 1995
45. Whitelock JM, Murdoch AD, lozzo RV, Underwood PA: The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromolysin, collagenase, plasmin, and heparanases, J Biol Chem 271:10079-10086, 1996
46. Wieman TJ, Smiell JM, Su Y: Efficacy and safety of a topical gel formulation of recombinant human platelet derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study, Diabetes Care 21:822-827, 1998